a public good project by the
Synthesis
Company
of California

© 2026

Weidong Ding | doi.page

0 works0 citations0 h-index

Weidong Ding

Pfizer (United States)(US)Beijing Anding Hospital(CN)Beijing Hospital(CN)

Publications by Year

Research Areas

Bioactive Compounds and Antitumor Agents, Cyclization and Aryne Chemistry, Protein Structure and Dynamics, Microbial Natural Products and Biosynthesis, Synthesis and Biological Evaluation

Most-Cited Works

→ Delineating the role of cooperativity in the design of potent PROTACs for BTK(2018)413 cited
→ Lomaiviticins A and B, Potent Antitumor Antibiotics from Micromonospora lomaivitiensis(2001)241 cited
→ Kinetic Mechanism of Staphylococcus aureus Sortase SrtA(2003)166 cited
→ Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based design(2006)91 cited
→ Namenamicin, a New Enediyne Antitumor Antibiotic from the Marine Ascidian Polysyncraton lithostrotum(1996)76 cited
→ Development of a fluorescence polarization assay to screen for inhibitors of the FtsZ/ZipA interaction(2003)75 cited
→

Pyranonaphthoquinone Lactones: A New Class of AKT Selective Kinase Inhibitors Alkylate a Regulatory Loop Cysteine

(2009)

72 cited

→ Pyrroindomycins, novel antibiotics produced by Streptomyces rugosporus sp. LL-42D005. I. Isolation and structure determination.(1994)61 cited

→ Design and synthesis of indolo[2,3-a]quinolizin-7-one inhibitors of the ZipA–FtsZ interaction(2004)60 cited

→ Discovery of lactoquinomycin and related pyranonaphthoquinones as potent and allosteric inhibitors of AKT/PKB: mechanistic involvement of AKT catalytic activation loop cysteines(2007)58 cited